Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessWhy is Under Armour CEO Patrik Frisk stepping down

Why is Under Armour CEO Patrik Frisk stepping down

Add to Favorite
Added to Favorite
Twitter Image Patrik Frisk

On Wednesday, Under Armour announced that their president and chief executive officer Patrik Frisk would be stepping down and chief operating officer Colin Browne would be the interim CEO, effective June 1. The announcement was made after the company released a disappointing quarterly report. The stock fell by over three percent in extended trading.

Although no reason has been given by either the company or Frisk, it was reportedly a decision that was reached mutually. Frisk will remain as a consultant through September 1. The stepping down decision was unexpected. Frisk joined the Baltimore based company in 2017 and has been leading it since more than two years. He had become the CEO on Jan 1, 2020, replacing founder Kevin Plank. He has not responded when asked for the reason of his departure, by multiple outlets.



In a statement on Wednesday, Frisk said that he was “extremely proud of what we’ve accomplished as a team.” He said that they had strengthened the iconic brand and had “significantly” solidified Under Armour’s operations.

His tenure, during the pandemic, saw the CEO take steps to bring about a turnaround by limiting discounts offered to third party retailers in order to boost profit. He also tried to make it a high end brand comparable with rivals Nike and Lululemon.

Under Armour has reported a loss in the transition quarter as it is shifting its fiscal year. Supply chain issues affected the brand and the recent Zero Covid policy in China decreased demand. This led to a disappointing outlook for fiscal year 2023, from April 1, 2022 through March 31, 2023.



The announcement also said that the board would be looking for a permanent replacement, internally and externally. Under Armor has seen close to 50 percent drop in share price this year, while rival Nike saw a drop of more than 34 percent.

On Wednesday evening, founder Kevin Plank told CNBC in a phone interview that the company will enter a new phase of growth by upgrading its e-commerce operations. He also said that he was not being considered for the role of CEO, as of now.

Subscribe to get Latest News Updates

Latest News

You may like more
more

Advance Auto Parts Downgraded to Sell Amid Earnings Miss and Weak Outlook

CFRA analysts downgraded Advance Auto Parts (NYSE:AAP) from Hold...

Guggenheim Reiterates Buy Rating on Cabaletta Bio Amid Promising Data

Guggenheim analysts reaffirmed a Buy rating and a $23...

Goldman Sachs Initiates Neutral Coverage on Doximity, Highlights Balanced Growth Potential

Goldman Sachs analysts initiated coverage on Doximity (NYSE:DOCS) with...

JPMorgan Downgrades bluebird bio to Underweight Following Q3 Results

JPMorgan analysts downgraded bluebird bio (NASDAQ:BLUE) from Neutral to...